RESMED INC — Director's Dealing 2013

Mar 5, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2013-03-01

Reporting Person: Douglas Robert Andrew (President and COO ResMed Inc.)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2013-03-04	ResMed Common Stock	M	7500	$21.025	Acquired	106830.588	Direct
2013-03-04	ResMed Common Stock	S	7500	$43.440	Disposed	99330.588	Direct
2013-03-04	ResMed Common Stock	S	500	$43.310	Disposed	98830.588	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2013-03-01	ResMed Common Stock Options	$43.63	A	46555	Acquired	2020-03-01	ResMed Common Stock (46555)	Direct
2013-03-04	ResMed Common Stock Options	$21.025	M	7500	Disposed	2014-11-07	ResMed Common Stock (7500)	Direct

Footnotes

F1: Represents date options first become exercisable. Options vest 1/3 per year on the anniversary of the grant.

F2: Trade executed pursuant to a 10b5-1 trading plan.

F3: Represents date options first became exercisable. Options vest 1/4 per year on the anniversary of the grant.

F4: This transaction was executed in multiple trades at prices ranging from $43.34 to $43.54. The price reported above reflects the weighted average sale price. The reporting person will provide full information regarding the number of shares and prices at which the transaction was effected upon request to the SEC staff, the issuer or the security holder of the issuer.